Privigen 10% vial 400ML
Ended Awarded Last action
- Contract number
- SPE2DR26FDJH0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,926
Award facts
- Contract value 100% obligated
- $27,926.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $27,926.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for PRIVIGEN 10% Vial 400ML. The delivery order, issued on December 11, 2025, with an ultimate completion date of January 5, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. Performance will occur in Park Ridge, IL.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion acquisition strategy designed to provide pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. The underlying IDC, awarded on November 13, 2025, features a 30-month base period with three 30-month option periods extending through December 31, 2036, and positions DMS Pharmaceutical Group as a regional prime vendor contractor. The company's established track record supplying diverse pharmaceutical categories—including specialty biologics, vaccines, oncology treatments, and routine medications—demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FDJH0?
SPE2DR26FDJH0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FDJH0 worth?
The government has obligated $27,926 on SPE2DR26FDJH0.
Is contract SPE2DR26FDJH0 an order under another contract?
Yes. SPE2DR26FDJH0 is a delivery order under SPE2DR25D9144, an indefinite delivery contract.
Was contract SPE2DR26FDJH0 competed?
The extent of competition for SPE2DR26FDJH0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award